Second-line Treatment of Primary Autoimmune Hemolytic Anemia

NCT05057468 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Primary Autoimmune Hemolytic Anemia

Interventions

DRUG: Cyclosporine
DRUG: Rituximab

Sponsor

Assiut University